** Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in Canada

Similar to the US arrangement, Ocugen will retain 45 per cent of the profit from sales of Covaxin in Canada.

Ocugen Inc, the US partner for Bharat Biotech’s COVID-19 vaccine has announced the payment of $15 million upfront to the Indian drug maker for extending the vaccine rights to Canada.

Ocugen in a regulatory filing said it has agreed to pay another $10 million to Bharat Biotech within a month from the commercial launch of Covaxin in the North American country.

** Battle against COVID: ISRO develops three types of ventilators, to transfer technology

Low-cost and portable critical care ventilator ‘PRANA’ (Programmable Respiratory Assistance for the Needy Aid) is based on the automated compression of an AMBU (Artificial Manual Breathing unit) bag

** Pfizer donates $70 mn worth COVID-19 treatment drugs to India

“We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India,” says Pfizer Chairman and CEO Albert Bourla

Global pharma major Pfizer is sending its medicines worth $70 million (over ₹510 crore), from its distribution centres in the U.S., Europe and Asia, that have been identified as part of India’s COVID-19 treatment protocol, the company’s Chairman and CEO Albert Bourla said on May 3.

** Australian cricketers to take part in COVID-19 fundraiser for India

The initiative will let fans watch the likes of Pat Cummins, spinner Nathan Lyon and the pace duo of Mitchell Starc and Josh Hazlewood on a live stream

Top Australian cricketers including star pacer Pat Cummins will participate in a 12-hour gaming live stream on Thursday to raise money for UNICEF Australia’s India COVID Appeal.

The brainchild of pacer Josh Lalor, the initiative will let fans watch the likes of Cummins, spinner Nathan Lyon and the pace duo of Mitchell Starc and Josh Hazlewood on a live stream when they talk about cricket and showcase their gaming skills in a bid to raise AUD 100,000.

** Andhra Pradesh Govt. nod for ‘Anandaiah preparation’, excluding eye drops

AYUSH chief says the concoction is not an ayurvedic medicine

The State government on Monday permitted the usage of the herbal preparation being given to COVID patients by B. Anandaiah, an ayurvedic practitioner of Krishnapatnam in Nellore district, by taking into account the findings of the Central Council for Research in Ayurvedic Sciences, but kept on hold its decision on the eye drops claimed to be life saving for those with dangerously low levels of oxygen.

While giving the green signal to the herbal preparation, the government warned that COVID patients should not stop taking the drugs prescribed by doctors in the normal course.

** BEML manufacturing medical oxygen units

In a bid to mitigate the oxygen shortage in the country, defence PSU major BEML has started manufacturing 960 LMP medical oxygen units at its KGF complex.

The units have been set up under a transfer of technology agreement with Defence Bio Engineering and Electro Medical Laboratory under the DRDO.

** IIT Ropar develops ‘AmbiTag’ to record real-time ambient temperature

Project Director Dr. Pushpendra P. Singh, said the device will be made available to all companies involved in COVID-19 vaccine transportation at a production cost of ₹400

Indian Institute of Technology in Punjab’s Ropar has developed a first-of-its-kind Internet of Things (IoT) device – AmbiTag.

** Coronavirus | Variant found in India to be called ‘Delta’ in new WHO system

The new names would only be to aid public discussion using labels that were “non stigmatising” to the countries where they were first identified.

The variant first identified in India, technically known as B.1.617.2, can now be described as ‘Delta’ and the so called ‘UK variant’ as ‘Alpha’ according to a note from the organization late on Monday.